|
Market Closed -
Nasdaq
21:00:00 10/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 27.00 USD | +0.04% |
|
-.--% | +67.18% |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell 2000 Growth Index | CI |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell Small Cap Comp Growth Index | CI |
| Market Cap | 1.44B 1.28B 1.17B 1.07B 2.01B 136B 2.05B 13.98B 5.61B 71.9B 5.39B 5.28B 228B | P/E 2024 |
-2.46x | P/E 2025 | -5.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42B 1.27B 1.16B 1.06B 1.99B 135B 2.03B 13.82B 5.55B 71.1B 5.33B 5.22B 225B | EV / Sales 2024 |
-
| EV / Sales 2025 | 10.9x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: KalVista Pharma
| 1 day | +0.04% | ||
| 6 months | +1.31% | ||
| Current year | +67.18% |
| Current year | 14.22 |  | 27 |
| 1 year | 10.41 | | 27 |
| 3 years | 7.21 | | 27 |
| 5 years | 4.12 | | 27 |
| 10 years | 0 | | 45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ed Feener
CTO | Chief Tech/Sci/R&D Officer | 66 | 31/10/2016 |
John Hess
PSD | President | - | 10/06/2026 |
Brian Piekos
DFI | Director of Finance/CFO | 51 | 08/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Hess
CHM | Chairman | - | 10/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/05/26 | Exercice | Executive/Senior Manager | 101,400 | 0.2006% | ||
| 26/05/26 | Sell | Executive/Senior Manager | -1,489 | 0.0029% | ||
| 26/05/26 | Sell | Executive/Senior Manager | -1,966 | 0.0039% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 73.62M 65.56M 60.12M 54.66M 103M 6.97B 105M 716M 287M 3.68B 276M 270M 11.66B |
| Net income | -127M -113M -103M -94.04M -177M -11.98B -181M -1.23B -494M -6.33B -475M -465M -20.06B | -164M -146M -134M -122M -230M -15.55B -235M -1.6B -641M -8.22B -617M -603M -26.02B |
| Net Debt | -203M -181M -166M -151M -284M -19.22B -290M -1.97B -792M -10.16B -762M -746M -32.16B | -16.01M -14.26M -13.07M -11.89M -22.37M -1.51B -22.86M -156M -62.45M -801M -60.07M -58.79M -2.54B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- KALV Stock
Select your edition
All financial news and data tailored to specific country editions
